Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3.
about
INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosisPathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variantsStrengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaborationChromosome 9p21 variant predicts mortality after coronary artery bypass graft surgeryAssociation between a literature-based genetic risk score and cardiovascular events in womenBivariate genetic association of KIAA1797 with heart rate in American Indians: the Strong Heart Family StudyGenetics of coronary artery disease and myocardial infarctionImproved prediction of complex diseases by common genetic markers: state of the art and further perspectivesAdvances in the use of multimarker panels for renal risk stratificationIdentifying novel biomarkers for cardiovascular disease risk predictionCardiovascular genomics: a biomarker identification pipelineGenomics: Implications for anesthesia, perioperative care and outcomesLack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studiesGenetic testing of children for predisposition to mood disorders: anticipating the clinical issuesFrom disease association to risk assessment: an optimistic view from genome-wide association studies on type 1 diabetes.Common genetic variants on chromosome 9p21 predict perioperative myocardial injury after coronary artery bypass graft surgery.Common genetic variants do not associate with CAD in familial hypercholesterolemia.Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events: a systematic review and meta-analysis.Genetic variants and their interactions in the prediction of increased pre-clinical carotid atherosclerosis: the cardiovascular risk in young Finns study.Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristicsThe contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study.The relationships between FAM5C SNP (rs10920501) variability and metabolic syndrome and inflammation in women with coronary heart diseaseThe association between variants on chromosome 9p21 and inflammatory biomarkers in ethnically diverse women with coronary heart disease: a pilot study.Assessing the Incremental Role of Novel and Emerging Risk Factors.The effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake: evidence from a case/control and a prospective study.Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery diseaseGenotype-informed estimation of risk of coronary heart disease based on genome-wide association data linked to the electronic medical record.General Cardiovascular Risk Profile identifies advanced coronary artery calcium and is improved by family history: the multiethnic study of atherosclerosis.The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop.Early identification of cardiovascular risk using genomics and proteomics.Validated context-dependent associations of coronary heart disease risk with genotype variation in the chromosome 9p21 region: the Atherosclerosis Risk in Communities study.Genome-wide association study of coronary artery disease.Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohortsImproved prediction of cardiovascular disease based on a panel of single nucleotide polymorphisms identified through genome-wide association studies.Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease.Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction.Variation in recovery: Role of gender on outcomes of young AMI patients (VIRGO) study design.Genetic cardiovascular risk prediction: will we get there?
P2860
Q21562488-32D85889-E1BF-4958-B8EA-CFF037377AD1Q24273409-A12F46EB-F02A-4AF4-B985-77B3778B98C5Q24289354-B7A5924A-9A89-4EC8-9791-E7E54804A293Q24289476-AA047CCA-7940-4F63-8286-4829783F8117Q24602703-C2311F1F-AB92-490D-AACD-182231D4233AQ24613965-117A76CA-29A8-4421-927B-2C9F72241F95Q24626784-344883DB-A11D-454F-A367-AE8E501DC84BQ26769994-A3CA69A9-9444-4D94-8C19-B762B056685DQ26770167-70FEB344-5806-4805-9AAE-1B4B742545C8Q26853272-218B2E7E-52ED-431D-9190-FB936E5B080EQ26865722-202880F2-16CA-494F-93B7-079EE55FA09AQ28596902-BA140F65-51E5-4289-946D-D9653BAB857CQ28752236-6A785C9C-41A3-4449-99FA-F2F8178CF451Q30499949-02AC0FE7-BE1B-482A-A240-9356CD701E6BQ30583355-D44E77AF-C124-48E8-9283-2D83F85FB3C7Q33509503-C8B28EBA-470B-401B-9D27-38E5047544E6Q33618526-5D950597-93A4-4105-A3BE-BCFFC5C0A95AQ33620844-7A5597C7-F8C5-4C36-AC19-161F4229BACFQ33673402-38A003C4-6A8C-40D2-B7CE-F696544B8EB4Q33717049-57DC7E0C-5465-4FFF-BDA2-9039C09269F5Q33764913-AF51A73E-0165-4D5C-94B1-6E6C8D71E3A3Q33846673-B83044F9-41A5-4A45-8E4D-B6F06950F651Q33942212-6354F2D9-50CD-4210-B776-69BE0D53A548Q33986857-7374547B-B7FA-46C8-AA2B-653474D0B0F2Q33995565-10A6A785-E944-4DDB-BEAC-42FD49A5B486Q34055191-C94DEF63-1932-4A88-A4EF-F8E42F9837BAQ34059033-BD73221B-6D4D-45DF-9AD7-D6A9B25FE59EQ34094016-D63E29C5-3582-426A-A060-DDB4252DC9E8Q34100785-20FC6E60-EE8C-4DB7-83F6-E7977C9ACC4EQ34113976-89C91AF2-B727-405A-9610-A7CE1E73F9E8Q34129889-09A506DE-FF16-49CF-9DD1-FA9F4A131BF5Q34180975-2FD85639-D1A9-4917-AE6C-FF95472F7728Q34218772-09F55651-AF72-427F-A520-D95FA054D58FQ34358091-F8B8BC87-6A8C-4B60-B060-903736407C11Q34559794-A2BB0ED5-D7BE-400F-9BC0-46E976BA72AFQ34562058-84D9A9C5-79B6-4831-AA90-8ECF7C9D651BQ34579841-E06A3B7A-EFE1-4462-A2C2-C0AB3D43371CQ34691058-250B590D-B81E-488F-9036-B98EAA2CF22FQ34725004-C2240F91-1CC9-47ED-BD8B-3E43462DE78EQ34787709-CE8E4D02-C64A-4055-A103-7F03A87A918E
P2860
Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiovascular disease risk pr ...... ariation at chromosome 9p21.3.
@en
Cardiovascular disease risk pr ...... ariation at chromosome 9p21.3.
@nl
type
label
Cardiovascular disease risk pr ...... ariation at chromosome 9p21.3.
@en
Cardiovascular disease risk pr ...... ariation at chromosome 9p21.3.
@nl
prefLabel
Cardiovascular disease risk pr ...... ariation at chromosome 9p21.3.
@en
Cardiovascular disease risk pr ...... ariation at chromosome 9p21.3.
@nl
P2093
P2860
P1476
Cardiovascular disease risk pr ...... ariation at chromosome 9p21.3.
@en
P2093
Daniel I Chasman
Dov Shiffman
Nancy R Cook
Nina P Paynter
Paul M Ridker
P2860
P356
10.7326/0003-4819-150-2-200901200-00003
P407
P577
2009-01-01T00:00:00Z